Evidence map›Paper›PMID 18849405›Full record

ArticleChest2009

Brain natriuretic peptide levels in managing pediatric patients with pulmonary arterial hypertension.

Anna Bernus, Brandie D Wagner, Frank Accurso, Aimee Doran, Heidi Kaess, D Dunbar Ivy

Open access · greenAbstract read
In one paragraph

Article in Chest, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Anna BernusUniversity of Colorado Denver School of Medicine, The Children's Hospital, Aurora, CO.
Brandie D WagnerUniversity of Colorado Denver School of Medicine, The Children's Hospital, Aurora, CO.
Frank AccursoUniversity of Colorado Denver School of Medicine, The Children's Hospital, Aurora, CO.
Aimee DoranUniversity of Colorado Denver School of Medicine, The Children's Hospital, Aurora, CO.
Heidi KaessUniversity of Colorado Denver School of Medicine, The Children's Hospital, Aurora, CO.
D Dunbar IvyUniversity of Colorado Denver School of Medicine, The Children's Hospital, Aurora, CO. Electronic address: dunbar.ivy@uchsc.edu.
Children's Hospital Colorado · USUniversity of Colorado Denver · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
ZORVIRAX ORAL SUSPENSION FOR SEVERE CHILDHOOD HERPES VIRUS INFECTIONSM01RR000069 · NCRR · UNIVERSITY OF COLORADO DENVER · PI KRUGMAN, RICHARD D. · 1985 to 2008
$22.1M
Non-Invasive Inhaled NO in Premature NewbornsP50HL084923 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI STENMARK, KURT R. · 2007 to 2012
$11.2M
LABORATORY COREU01HL081335 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI ACCURSO, FRANK J. · 2005 to 2008
$4.1M
NCRR NIH HHS M01 RR000069NCRR NIH HHS M01 RR 00069NCRR NIH HHS UL1 RR 025780NCRR NIH HHS UL1 RR025780NHLBI NIH HHS P50 HL 084923NHLBI NIH HHS P50 HL084923NHLBI NIH HHS U01 HL 081335NHLBI NIH HHS U01 HL081335
6 · The paper itself

Abstract

backgroundPulmonary arterial hypertension (PAH) is an important determinant of morbidity and mortality in children. In this study, we aimed to investigate the value of brain natriuretic peptide (BNP) in a cohort of children with PAH, with respect to monitoring disease severity as assessed by hemodynamic and echocardiographic parameters.

methodsWe performed a prospective study to determine whether BNP varies over time in this population and whether these changes track with hemodynamic or echocardiographic parameters. The population included a group of 78 pediatric patients from January 2005 to April 2008. All patients had received a diagnosis of PAH and had serum BNP, catheterization, and echocardiographic variables collected longitudinally.

resultsThe median BNP level, for all observations, was 36 pg/mL (interquartile range, 18 to 76 pg/mL). There was no strong correlation found between commonly used echocardiographic or hemodynamic data and BNP. However, using a bivariate model, the change in BNP measurements over time significantly correlated with the change in the hemodynamic and echocardiographic parameters. Patients with a BNP value > 180 pg/mL had a decreased survival rate.

conclusionsBNP could be a useful marker to monitor disease severity in pediatric PAH. We show that simple correlations between variables and BNP are not likely to illustrate its usefulness due to variations in the normative levels. Instead, we propose that patient BNP levels should be monitored over time, as changes in BNP within a patient are likely to be more informative.

Indexed as

AdolescentBiomarkersChildChild, PreschoolEchocardiographyFemaleHemodynamicsHumansHypertension, PulmonaryInfantMaleNatriuretic Peptide, BrainPrognosisSurvival RateBiomarkersNatriuretic Peptide, Brain

Identifiers

PMID18849405
PMCPMC2715554
OpenAlexW2161728686

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.